What are the potential neurological side effects of adalimumab, specifically related to posterior reversible encephalopathy syndrome (PRES)?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18415965
Cited by: 0

Abstract

The evidence suggests adalimumab is associated with neurological side effects, particularly demyelinating disorders, but there is insufficient evidence directly linking it to PRES.

Fields of Study & Subjects

Neurological Complications and Syndromes Drug-Induced Ocular Toxicity Cerebral Venous Sinus Thrombosis

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
29 January 2026